Gennari A - Search Results

1

The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer.

Gennari A, Donati S, Danesi R, Fogli S, Orlandini C, Del Tacca M, Conte PF. Gennari A, et al. Semin Oncol. 2000 Feb;27(1 Suppl 2):14-9. Semin Oncol. 2000. PMID: 10697031 Clinical Trial.

2

A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer.

Conte PF, Michelotti A, Baldini E, Salvadori B, Gennari A, Da Prato M, Tibaldi C, Salzano E, Gentile A. Conte PF, et al. Among authors: gennari a. Semin Oncol. 1996 Oct;23(5 Suppl 11):28-31. Semin Oncol. 1996. PMID: 8893896 Clinical Trial.

3

Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.

Michelotti A, Gennari A, Salvadori B, Giannessi PG, Baldini E, Tibaldi C, Da Prato M, Conte PF. Michelotti A, et al. Among authors: gennari a. Semin Oncol. 1996 Oct;23(5 Suppl 11):38-40. Semin Oncol. 1996. PMID: 8893898 Clinical Trial.

4

Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II study.

Michelotti A, Gennari A, Salvadori B, Tognoni A, Tibaldi C, Baldini E, Conte PF. Michelotti A, et al. Among authors: gennari a. Ann Oncol. 1996 Oct;7(8):857-60. doi: 10.1093/oxfordjournals.annonc.a010767. Ann Oncol. 1996. PMID: 8922202 Free article. Clinical Trial.

5

Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.

Conte PF, Baldini E, Michelotti A, Salvadori B, Gennari A, Da Prato M, Tibaldi C, Giannessi PG, Gentile A. Conte PF, et al. Among authors: gennari a. Semin Oncol. 1996 Dec;23(6 Suppl 15):39-42. Semin Oncol. 1996. PMID: 8996597 Review.

6

Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel.

Gennari A, Salvadori B, Tognoni A, Conte PF. Gennari A, et al. Ann Oncol. 1996 Nov;7(9):978-9. doi: 10.1093/oxfordjournals.annonc.a010806. Ann Oncol. 1996. PMID: 9006754 Free article. Clinical Trial. No abstract available.

7

Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.

Conte PF, Baldini E, Gennari A, Michelotti A, Salvadori B, Tibaldi C, Danesi R, Innocenti F, Gentile A, Dell'Anna R, Biadi O, Mariani M, Del Tacca M. Conte PF, et al. Among authors: gennari a. J Clin Oncol. 1997 Jul;15(7):2510-7. doi: 10.1200/JCO.1997.15.7.2510. J Clin Oncol. 1997. PMID: 9215819 Clinical Trial.

8

Anthracyclines-paclitaxel combinations in the treatment of breast cancer.

Conte PF, Gennari A. Conte PF, et al. Among authors: gennari a. Ann Oncol. 1997 Oct;8(10):939-43. doi: 10.1023/a:1008208002779. Ann Oncol. 1997. PMID: 9402164 Free article. Review. No abstract available.

9

Paclitaxel plus epirubicin in advanced breast cancer.

Conte PF, Gennari A, Salvadori B, Pazzagli C, Bengala C. Conte PF, et al. Among authors: gennari a. Oncology (Williston Park). 1998 Jan;12(1 Suppl 1):40-4. Oncology (Williston Park). 1998. PMID: 9516603 Free article. Clinical Trial.

10

Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors.

Gennari A, Salvadori B, Donati S, Bengala C, Orlandini C, Danesi R, Del Tacca M, Bruzzi P, Conte PF. Gennari A, et al. J Clin Oncol. 1999 Nov;17(11):3596-602. doi: 10.1200/JCO.1999.17.11.3596. J Clin Oncol. 1999. PMID: 10550159 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters